Lausanne, Switzerland

Matthieu Perreau


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthieu Perreau: Innovator in Tuberculosis Differentiation Methods

Introduction

Matthieu Perreau is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical research, particularly in the differentiation of disease states related to Tuberculosis.

Latest Patents

Perreau holds a patent titled "Methods for differentiating between disease states." This patent focuses on innovative methods for distinguishing between mammals with active and latent Tuberculosis disease. The techniques involve determining the percentage of polyfunctional CD4+ T-cells that express TNF-alpha, IFN-gamma, and IL-2, or by assessing the expression of IL-17. He has 1 patent to his name.

Career Highlights

Throughout his career, Matthieu Perreau has been dedicated to advancing medical science. His work has implications for improving diagnostic methods for Tuberculosis, which is a significant global health concern.

Collaborations

Perreau has collaborated with esteemed colleagues in his field, including Giuseppe Pantaleo and Alexandre Harari. These partnerships have enhanced the impact of his research and contributed to the advancement of medical knowledge.

Conclusion

Matthieu Perreau is a distinguished inventor whose work in Tuberculosis differentiation methods showcases his commitment to improving healthcare. His innovative approaches have the potential to make a significant difference in the diagnosis and treatment of this disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…